Dermtech Stock Return On Equity
| DMTK Stock | USD 0.61 0.01 0.97% |
DermTech fundamentals help investors to digest information that contributes to DermTech's financial success or failures. It also enables traders to predict the movement of DermTech Stock. The fundamental analysis module provides a way to measure DermTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DermTech stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (1.76) | (1.68) |
DermTech | Return On Equity |
DermTech Company Return On Equity Analysis
DermTech's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current DermTech Return On Equity | -1.06 |
Most of DermTech's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DermTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DermTech Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for DermTech is extremely important. It helps to project a fair market value of DermTech Stock properly, considering its historical fundamentals such as Return On Equity. Since DermTech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DermTech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DermTech's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
DermTech Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, DermTech has a Return On Equity of -1.0646. This is 95.56% lower than that of the Biotechnology sector and 84.06% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
DermTech Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DermTech's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics of similar companies.DermTech is currently under evaluation in return on equity category among related companies.
DermTech Fundamentals
| Return On Equity | -1.06 | ||||
| Return On Asset | -0.38 | ||||
| Operating Margin | (5.03) % | ||||
| Current Valuation | 19.86 M | ||||
| Shares Outstanding | 34.62 M | ||||
| Shares Owned By Insiders | 4.24 % | ||||
| Shares Owned By Institutions | 21.08 % | ||||
| Number Of Shares Shorted | 3.16 M | ||||
| Price To Earning | (139.70) X | ||||
| Price To Book | 0.38 X | ||||
| Price To Sales | 1.41 X | ||||
| Revenue | 15.3 M | ||||
| Gross Profit | 647 K | ||||
| EBITDA | (97.89 M) | ||||
| Net Income | (100.89 M) | ||||
| Cash And Equivalents | 173.79 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 54.39 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 12.19 X | ||||
| Book Value Per Share | 1.66 X | ||||
| Cash Flow From Operations | (76.98 M) | ||||
| Short Ratio | 6.32 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Target Price | 2.04 | ||||
| Number Of Employees | 206 | ||||
| Beta | 2.56 | ||||
| Market Capitalization | 21.33 M | ||||
| Total Asset | 121.93 M | ||||
| Retained Earnings | (423.94 M) | ||||
| Working Capital | 48.3 M | ||||
| Current Asset | 140.61 K | ||||
| Current Liabilities | 446.54 K | ||||
| Net Asset | 121.93 M |
About DermTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DermTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DermTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DermTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DermTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DermTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DermTech will appreciate offsetting losses from the drop in the long position's value.Moving against DermTech Stock
| 0.86 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.75 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.73 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.7 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.54 | CGC | Canopy Growth Corp Trending | PairCorr |
The ability to find closely correlated positions to DermTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DermTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DermTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DermTech to buy it.
The correlation of DermTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DermTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DermTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DermTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DermTech Piotroski F Score and DermTech Altman Z Score analysis. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.